|
Volumn 39, Issue 997, 1997, Pages 29-31
|
Atorvastatin - A new lipid-lowering drug
f a f f b c d e c
f
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTILIPEMIC AGENT;
ATORVASTATIN;
CHOLESTEROL;
CLOFIBRATE;
COLESTIPOL;
COLESTYRAMINE;
CYCLOSPORIN;
CYCLOSPORIN A;
DIGOXIN;
ERYTHROMYCIN;
FENOFIBRATE;
FLUINDOSTATIN;
GEMFIBROZIL;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
ITRACONAZOLE;
KETOCONAZOLE;
LIPID;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MEVINOLIN;
NICOTINIC ACID;
PRAVASTATIN;
PREVALITE;
SIMVASTATIN;
TRIACYLGLYCEROL;
UNCLASSIFIED DRUG;
ACUTE KIDNEY FAILURE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG COST;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MECHANISM;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIA;
LIVER DYSFUNCTION;
MYALGIA;
RHABDOMYOLYSIS;
SHORT SURVEY;
ANTI-BACTERIAL AGENTS;
ANTICHOLESTEREMIC AGENTS;
ANTIFUNGAL AGENTS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
ERYTHROMYCIN;
HEPTANOIC ACIDS;
HUMANS;
HYPERCHOLESTEROLEMIA;
HYPERLIPIDEMIAS;
KETOCONAZOLE;
PYRROLES;
|
EID: 0040926830
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (10)
|
References (11)
|